Our recent investigations indicate that PKM2 is intricately regulated by the transcriptional coactivator PGC1α, influencing glycolytic pathways and Wnt/β-catenin signaling in CRC cells. The gene discussed is PPARGC1A; the disease is colorectal carcinoma.